Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
18.49
-1.56 (-7.78%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $602.43 million as of October 26, 2026. It is the 13,232nd most valuable company in the world and the 2,600th biggest in the United States. Its market cap has increased by 281.69% in one year.
Market Cap
602.43M
Enterprise Value
580.27M
1-Year Change
281.69%
Global Rank
Country Rank
#2,600 United States
Category
ChartMarket Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $602.43M, an increase of 938.58%. That is a compound annual growth rate of 64.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 602.43M | 211.51% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Iambic Therapeutics | 675.94M |
| Immix Biopharma | 675.66M |
| Ginkgo Bioworks Holdings | 672.73M |
| Achieve Life Sciences | 667.84M |
| SL Science Holding | 655.81M |
| Aura Biosciences | 653.34M |
| Prime Medicine | 652.91M |
| Design Therapeutics | 640.84M |